Regulation of the HIV Promoter/Enhancer.

Regulation of the HIV Promoter/Enhancer. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Regulation of the HIV Promoter/Enhancer. Abstract Text:

This unit describes adaptations of two molecular techniques that can be used to study the regulation of HIV expression. The first two protocols describe the chloramphenicol acetyltransferase (CAT) assay, in which the CAT reporter gene is attached to an HIV-1 promoter and CAT activity is measured as an indication of the promoter's activity. The basic protocol is rapid, simple, and suited to analyzing multiple samples. An alternate protocol describes an assay for CAT function that involves separating the reaction products by thin-layer chromatography (TLC). The second basic protocol describes an electrophoretic mobility shift assay for detecting proteins present in cell extracts that can bind to the HIV-1 LTR (long terminal repeat). Such studies are central to current HIV research because it is important to know what agents induce and inhibit (or "down-regulate") HIV transcription.

Regulation of the HIV Promoter/Enhancer. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Regulation of the HIV Promoter/Enhancer. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Current protocols in immunology / edited by John E

VOLUME: Chapter 12

Page Numbers: Unit12.7

Journal Abbreviation:

ISSN: 1934-368X

DAY: 24

MONTH: May

YEAR: 2003

Regulation of the HIV Promoter/Enhancer. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9101651

Regulation of the HIV Promoter/Enhancer. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Regulation of the HIV Promoter/Enhancer. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Regulation of the HIV Promoter/Enhancer.

AFFILIATION: Department of Clinical and Experimental Medicine, University of Catanzaro, Magna Grecia, Cantazaro, Italy.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Curr Protoc Immunol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Regulation of the HIV Promoter/Enhancer Related Publications

• A GERIATRIC MENTAL HYGIENE CLINIC IN A GENERAL HOSPITAL: FIRST TWO YEARS OF OPERATION.
• Aluminum stimulates uptake of non-transferrin bound iron and transferrin bound iron in human glial cells.
• Cancer of the rectum and pregnancy.
• Comparison costs for Hemoccult tests.
• Comparison of methods to identify incident cataract in eyes of patients with neovascular maculopathy: Submacular Surgery Trials Report No. 18.
• Incident choroidal neovascularization in fellow eyes of patients with unilateral subfoveal choroidal neovascularization secondary to age-related macular degeneration: SST report No. 20 from the Submacular Surgery Trials Research Group.
• Industrial separation of carboxylic and amino acids by liquid membranes: Applicability, process considerations, and potential advantage.
• Measurement of the position and displacement of a light beam with a spiral scanner.
• Numbering of lumbosacral transitional vertebrae on MRI.
• Optic atrophy and an ocular complication of diabetes mellitus simulating the Foster Kennedy syndrome.
• Pneumonectomy for pulmonary tuberculosis in a woman 6 months pregnant, followed by a normal birth.
• Regulation of the HIV Promoter/Enhancer.
• Spatial organization of EEGs from olfactory bulb and cortex.
• The use of the right colon as a substitute gastric pouch after total gastrectomy.
• Treatment of subfoveal choroidal neovascularisation in age related macular degeneration: focus on clinical application of verteporfin photodynamic therapy.
• Trial-to-trial variability of cortical evoked responses: implications for the analysis of functional connectivity.
• Vitamin usage patterns in the prevention of advanced age-related macular degeneration.